Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose for Pediatric Iron Deficiency Anemia in the ED
NCT07414199Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Orange County
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Children's Hospital of Orange County. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07414199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07414199.